The tumor immune microenvironment shapes response to pembrolizumab in microsatellite instability-high endometrial cancer

被引：0
|
作者：
How, Jeffrey [1 ]
Dang, Minghao [1 ]
Euscher, Elizabeth [1 ]
Yates, Melinda [1 ]
Peng, Weiyi [2 ]
Patel, Shrina [1 ]
Lu, Karen [1 ]
Hwu, Patrick [1 ]
Naing, Aung [1 ]
Wang, Linghua [1 ]
Jazaeri, Amir [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Houston, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
584
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [31] Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
    Fuca, Giovanni
    Corti, Francesca
    Ambrosini, Margherita
    Intini, Rossana
    Salati, Massimiliano
    Fenocchio, Elisabetta
    Manca, Paolo
    Manai, Chiara
    Daniel, Francesca
    Raimondi, Alessandra
    Morano, Federica
    Corallo, Salvatore
    Prisciandaro, Michele
    Spallanzani, Andrea
    Quara, Virginia
    Belli, Carmen
    Vaiani, Marta
    Curigliano, Giuseppe
    Cremolini, Chiara
    De Braud, Filippo
    Di Bartolomeo, Maria
    Zagonel, Vittorina
    Lonardi, Sara
    Pietrantonio, Filippo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [32] Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
    Yoshida, Tsukasa
    Yaegashi, Hiroshi
    Toriumi, Ren
    Kadomoto, Suguru
    Iwamoto, Hiroaki
    Izumi, Kouji
    Kadono, Yoshifumi
    Ikeda, Hiroko
    Mizokami, Atsushi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
    Guedikian, Annie A.
    Randall, Megan E.
    Sharko, Anita
    Leslie, William T.
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1414 - 1417
  • [34] Pembrolizumab in the Treatment of Microsatellite Instability-High Sebaceous Carcinoma: A Case Report With Review of the Literature
    Banerjee, Natasha
    Hossain, Farhana
    Wirtschafter, Eric
    Fathizadeh, Payman
    JCO PRECISION ONCOLOGY, 2020, 4 : 61 - 65
  • [35] Response to nivolumab and ipilimumab in microsatellite instability-high (MSI-H) cervical carcinoma with acquired resistance to pembrolizumab
    Gim, Gahyun
    Cho, Sukjoo
    Lee, Dongyup
    Park, Jonghanne
    Kim, Leeseul
    Choi, Horyun
    Kang, Cyra Y.
    Vagia, Elena
    Viveiros, Pedro
    Chae, Young Kwang
    CANCER RESEARCH, 2020, 80 (16)
  • [36] Anti-programmed Death-1 Immunotherapy for Endometrial Cancer with Microsatellite Instability-High Tumors
    Sobecki-Rausch, Janelle
    Barroilhet, Lisa
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [37] Frequency and characteristic of microsatellite Instability-high cancer in our hospital
    Saito, Akihisa
    Kuraoka, Kazuya
    Ishikawa, Akira
    Zaitsu, Junichi
    Taniyama, Kiyomi
    CANCER SCIENCE, 2021, 112 : 793 - 793
  • [38] Designing Trials for Neoadjuvant Immune Checkpoint Inhibition in Microsatellite Instability-High Localized Colorectal Cancer
    Andre, Thierry
    Cohen, Romain
    JCO ONCOLOGY PRACTICE, 2023, 19 (05) : 261 - +
  • [39] Dual checkpoint blockade for microsatellite instability-high colorectal cancer
    Haldar, S. Daniel
    Kopetz, Scott
    LANCET, 2025, 405 (10476):
  • [40] Immune microenvironmental heterogeneity according to tumor DNA methylation phenotypes in microsatellite instability-high colorectal cancers
    Kim, Jung Ho
    Hong, Jiyun
    Lee, Ji Ae
    Jung, Minsun
    Choi, Eunwoo
    Cho, Nam-Yun
    Kang, Gyeong Hoon
    Kim, Sangwoo
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
12345